Following GVHD induction using donor splenocytes, anti-murine PD-1 monoclonal antibodies (mAB) or PD-L1 fusion proteins were administered, which block PD-1 signaling with its ligand. The gene discussed is PDCD1; the disease is graft versus host disease.